Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of VanEck Biotech ETF (NASDAQ:BBH) through any online brokerage.
There are no as such competitors for VanEck Biotech ETF.
There is no analysis for VanEck Biotech ETF to provide a consensus price target.
The stock price for VanEck Biotech ETF (NASDAQ: BBH) is $236.04 last updated September 8, 2026 at 9:29 AM EDT.
There are no upcoming dividends for VanEck Biotech ETF.
VanEck Biotech ETF does not have any upcoming earnings scheduled.
There is no upcoming split for VanEck Biotech ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Growth |
| Fund Inception | Dec 20, 2011 |
| Managers | Peter H. Liao Griffin Driscoll |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| AMGN | Amgen Inc. | 16.6% |
| VRTX | Vertex Pharmaceuticals... | 8.58% |
| REGN | Regeneron Pharmaceutic... | 7.39% |
| GILD | Gilead Sciences Inc | 12.9% |
| AS | Argenx Se Sponsored Ad... | 4.49% |
| IQV | Iqvia Holdings Inc. | 5.08% |
| NTRA | Natera Inc | 4.80% |
| RVMD | Revolution Medicines I... | 5.36% |
| ILMN | Illumina, Inc. | 3.48% |
| BIIB | Biogen Inc. | 3.35% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
